Determinants of sensitivity to radiotherapy in endometrial cancer
MetadataShow full item record
Radiotherapy is one of the cornerstone treatments for endometrial cancer and has successfully diminished the risk of local recurrences after surgery. However, a considerable percentage of patients suffers tumor relapse due to radioresistance mechanisms. Knowledge about the molecular determinants that confer radioresistance or radiosensitivity in endometrial cancer is still partial, as opposed to other cancers. In this review, we have highlighted different central cellular signaling pathways and processes that are known to modulate response to radiotherapy in endometrial cancer such as PI3K/AKT, MAPK and NF-kappa B pathways, growth factor receptor signaling, DNA damage repair mechanisms and the immune system. Moreover, we have listed different clinical trials employing targeted therapies against some of the aforementioned signaling pathways and members with radiotherapy. Finally, we have identified the latest advances in radiotherapy that have started being utilized in endometrial cancer, which include modern radiotherapy and radiogenomics. New molecular and genetic studies in association with the analysis of radiation responses in endometrial cancer will assist clinicians in taking suitable decisions for each individual patient and pave the path for personalized radiotherapy.
Is part ofCancers, 2020, vol. 12, núm. 7, p.1-26
European research projects
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
Combination of Vorinostat and caspase-8 inhibition exhibitshigh anti-tumoral activity on endometrial cancer cells Eritja Sánchez, Núria; Bergadà Bertran, Laura; Sorolla Bardají, Anabel; Yeramian Hakim, Andree; Mirantes, Cristina; Matias-Guiu, Xavier; Dolcet Roca, Xavier (Elsevier, 2013)Histone deacetylase inhibitors such as Vorinostat display anti-neoplastic activity against avariety of solid tumors. Here, we have investigated the anti-tumoral activity of Vorinostaton endometrial cancer cells. We have ...
Wang, Edina; Sorolla Bardají, Maria Alba; Gopal Krishnan, Priya Darshini; Sorolla, Anabel (MDPI, 2020)The marine environment represents an outstanding source of antitumoral compounds and, at the same time, remains highly unexplored. Organisms living in the sea synthesize a wide variety of chemicals used as defense mechanisms. ...
Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation Martínez Alonso, Montserrat; Llecha Cano, Núria; Mayorga Mayorga, Maritza Elfride; Sorolla Bardají, Anabel; Dolcet Roca, Xavier; Sanmartín Novell, Verònica; Abal Diaz, Leandro; Casanova i Seuma, Josep M. (Josep Manel); Baradad Brusau, Manuel; Yeramian Hakim, Andree; Egido Garcia, Ramon Maria; Puig, Susana; Vilella, Ramón; Matias-Guiu, Xavier; Martí Laborda, Rosa Ma. (Field House Publishing, 2009)Somatostatin analogues (SAs) are potential anticancer agents. This study was designed to investigate the expression of somatostatin receptors (SSTRs) in melanoma cells and the effect of two SAs on cell proliferation and ...